Altamira Therapeutics and Nuance Pharma Expand Bentrio’s Reach in Asia
Swiss pharmaceutical firm Altamira Therapeutics Ltd (NASDAQ: CYTO) and its Chinese partner Nuance Pharma have...
Swiss pharmaceutical firm Altamira Therapeutics Ltd (NASDAQ: CYTO) and its Chinese partner Nuance Pharma have...
Sanofi (EPA: SAN; NASDAQ: SNY), a leading French pharmaceutical company, has entered into a significant...
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has disclosed plans to acquire...
MDCO, an ophthalmic medical device company headquartered in Hangzhou, has reportedly secured nearly RMB 200...
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd (SHA: 603392), a leading biopharmaceutical company based in...
MGI Tech Co., Ltd, a prominent gene sequencing company based in China, has disclosed a...
MGI Tech Co., Ltd, a leading gene sequencing specialist based in China, has entered into...
Sino Biological (SHE: 301047), a leading biotech company in China, and BioGeometry have announced an...
Alibaba Health Information Technology Ltd (HKG: 0241), the health industry arm of Chinese e-commerce giant...
Shanghai Bao Pharmaceutical, a Chinese pharmaceutical company, along with its wholly-owned subsidiary Suzhou Centergene Pharmaceuticals,...
ChemPartner Pharmatech Co., Ltd (SHE: 300149), a leading pharmaceutical company based in China, has joined...
Nona Biosciences, a subsidiary of HBM Holdings Ltd (HKG: 2142), has entered into a strategic...
MoleculeMind, a Beijing-based AI protein design platform, has reportedly secured a Series A financing round,...
Autobio Diagnostics Co., Ltd (SHA: 603658), a prominent player in China’s in vitro diagnostic market,...
Luye Pharma Group (HKG: 2186), a leading pharmaceutical company based in China, has announced a...
Signet Therapeutics, a pioneering biopharmaceutical company in China specializing in cancer targeted therapies based on...
CSA Medical Inc., a U.S.-based medical technology company, has successfully closed a Series D financing...
Gilead Sciences Inc. (NASDAQ: GILD), a biopharmaceutical company based in the U.S., has entered into...
Carisma Therapeutics Inc. (NASDAQ: CARM), a U.S.-based company specializing in chimeric antigen receptor (CAR) macrophage...
Itcure, a prominent gene editing specialist headquartered in Suzhou, has announced separate strategic collaborations with...